<?xml version="1.0" encoding="UTF-8"?>
<ref id="B66-pharmaceuticals-13-00313">
 <label>66.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Grienke</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Schmidtke</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>von Grafenstein</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kirchmair</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Liedl</surname>
    <given-names>K.R.</given-names>
   </name>
   <name>
    <surname>Rollinger</surname>
    <given-names>J.M.</given-names>
   </name>
  </person-group>
  <article-title>Influenza neuraminidase: A druggable target for natural products</article-title>
  <source>Nat. Prod. Rep.</source>
  <year>2012</year>
  <volume>29</volume>
  <fpage>11</fpage>
  <lpage>36</lpage>
  <pub-id pub-id-type="doi">10.1039/C1NP00053E</pub-id>
  <pub-id pub-id-type="pmid">22025274</pub-id>
 </element-citation>
</ref>
